Literature DB >> 7946099

Comparison of in vivo plasma and peripheral blood mononuclear cell HIV-1 quasi-species to short-term tissue culture isolates: an analysis of tat and C2-V3 env regions.

E Sabino1, L Z Pan, C Cheng-Mayer, A Mayer.   

Abstract

OBJECTIVE: To determine whether the HIV-1 genomes that grow out in vitro from peripheral blood mononuclear cells (PBMC) better represent the in vivo quasi-species present in plasma or PBMC.
RESULTS: For one patient (9606), PBMC culture represented more accurately the plasma rather than the in vivo PBMC quasi-species distribution, because a large number of tat-defective proviruses present in PBMC in vivo were not detected in plasma nor in the PBMC cultures. For a second patient (9605), PBMC culture was representative of both in vivo PBMC and plasma tat sequences, but selection of C2-V3 env sequences was observed in PBMC cultures compared with sequences present in both plasma and PBMC in vivo. This selection consisted of the absence in vitro of genomes with certain amino-acid substitutions at or near conserved glycosylation sites of the C2 region at positions 276 and 289. Site 276 has been reported to be important for viral infectivity, and these substitutions may therefore have affected infectivity. In the third patient (10095), selection of both tat and C2-V3 sequences was observed in culture as compared to plasma and PBMC in vivo. In contrast to the first two patients, this third patient contained V3 sequences in vivo that were predicted to impart syncytium induction and enhanced replication capacity. It was these sequences that grew out preferentially in vitro.
CONCLUSION: This study suggests that short-term PBMC culture is representative of HIV-1 genomes present in PBMC and plasma in vivo to the degree that they are infectious.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7946099

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay.

Authors:  J A Nelson; S A Fiscus; R Swanstrom
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group.

Authors:  R S Diaz; E C Sabino; A Mayer; J W Mosley; M P Busch
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

3.  Mechanisms of human immunodeficiency virus Type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody.

Authors:  J S McDougal; M S Kennedy; S L Orloff; J K Nicholson; T J Spira
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood.

Authors:  A Singh; G Besson; A Mobasher; R G Collman
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Few mutations in the 5' leader region mediate fitness recovery of debilitated human immunodeficiency type 1 viruses.

Authors:  Eloísa Yuste; Antonio V Bordería; Esteban Domingo; Cecilio López-Galíndez
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Generation of representative primary virus isolates from blood plasma after isolation of HIV-1 with CD44 MicroBeads.

Authors:  Marion Cornelissen; Edwin J Heeregrave; Fokla Zorgdrager; Georgios Pollakis; William A Paxton; Antoinette C van der Kuyl
Journal:  Arch Virol       Date:  2010-09-24       Impact factor: 2.574

7.  Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses.

Authors:  David H O'Connor; Bianca R Mothe; Jason T Weinfurter; Sarah Fuenger; William M Rehrauer; Peicheng Jing; Richard R Rudersdorf; Max E Liebl; Kendall Krebs; Joshua Vasquez; Elizabeth Dodds; John Loffredo; Sarah Martin; Adrian B McDermott; Todd M Allen; Chenxi Wang; G G Doxiadis; David C Montefiori; Austin Hughes; Dennis R Burton; David B Allison; Steven M Wolinsky; Ronald Bontrop; Louis J Picker; David I Watkins
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Characterization of the Drug Resistance Profiles of Patients Infected with CRF07_BC Using Phenotypic Assay and Ultra-Deep Pyrosequencing.

Authors:  Szu-Wei Huang; Wei-You Li; Wen-Hung Wang; Yu-Ting Lin; Chih-Hung Chou; Marcelo Chen; Hsien-Da Huang; Yen-Hsu Chen; Po-Liang Lu; Sheng-Fan Wang; Shinichi Oka; Yi-Ming Arthur Chen
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

9.  Molecular Antiretroviral Resistance Markers of Human Immunodeficiency Virus-1 of CRF01_AE Subtype in Bali, Indonesia.

Authors:  Nyoman Sri Budayanti; Tuti Parwati Merati; Budiman Bela; Gusti Ngurah Mahardika
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

10.  Adaptation of HIV-1 depends on the host-cell environment.

Authors:  Tim van Opijnen; Anthony de Ronde; Maarten C Boerlijst; Ben Berkhout
Journal:  PLoS One       Date:  2007-03-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.